The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect

dc.contributor.author Rasmi, Yousef
dc.contributor.author Jalali, Ladan
dc.contributor.author Khalid, Saliha
dc.contributor.author Shokati, Ameneh
dc.contributor.author Tyagi, Poonam
dc.contributor.author Ozturk, Alpaslan
dc.contributor.author Nasimfar, Amir
dc.date.accessioned 2023-10-19T15:11:32Z
dc.date.available 2023-10-19T15:11:32Z
dc.date.issued 2023
dc.description.abstract Prolactin (PRL) is an endocrine hormone secreted by the anterior pituitary gland that has a variety of physiological effects, including milk production, immune system regulation, and anti-inflammatory effects. Elevated levels of PRL have been found in several viral infections, including 2019 coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), a viral pathogen that has recently spread worldwide. PRL production is increased in SARS-CoV2 infection. While PRL can trigger the production of proinflammatory cytokines, it also has several anti-inflammatory effects that can reduce hyperinflammation. The exact mechanism of PRL's contribution to the severity of COVID-19 is unknown. The purpose of this review is to discuss the interaction between PRL and SARS-CoV2 infection and its possible association with the severity of COVID-19. en_US
dc.identifier.doi 10.1016/j.cyto.2023.156253 en_US
dc.identifier.issn 1043-4666
dc.identifier.issn 1096-0023
dc.identifier.scopus 2-s2.0-85162171729 en_US
dc.identifier.uri https://doi.org/10.1016/j.cyto.2023.156253
dc.identifier.uri https://hdl.handle.net/20.500.12469/5061
dc.language.iso en en_US
dc.publisher Academic Press Ltd- Elsevier Science Ltd en_US
dc.relation.ispartof Cytokine en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Necrosis-Factor-Alpha En_Us
dc.subject Activated Macrophages En_Us
dc.subject Signal-Transduction En_Us
dc.subject Growth-Hormone En_Us
dc.subject C-Jun En_Us
dc.subject Expression En_Us
dc.subject Cell En_Us
dc.subject Receptor En_Us
dc.subject Mechanisms En_Us
dc.subject Release En_Us
dc.subject Necrosis-Factor-Alpha
dc.subject Activated Macrophages
dc.subject Signal-Transduction
dc.subject Growth-Hormone
dc.subject C-Jun
dc.subject Expression
dc.subject Prolactin en_US
dc.subject Cell
dc.subject SARS-CoV-2 en_US
dc.subject Receptor
dc.subject Severity en_US
dc.subject Mechanisms
dc.subject COVID-19 en_US
dc.subject Release
dc.subject Immunomodulatory effects en_US
dc.title The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.bip.impulseclass C4
gdc.bip.influenceclass C5
gdc.bip.popularityclass C4
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.departmenttemp [Rasmi, Yousef; Jalali, Ladan] Urmia Univ Med Sci, Fac Med, Dept Biochem, Orumiyeh, Iran; [Khalid, Saliha] Kadir Has Univ, Sch Engn & Nat Sci, Dept Bioinformat & Genet, Cibali Campus Fatih, TR-34083 Istanbul, Turkiye; [Shokati, Ameneh] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Appl Cell Sci, Tehran, Iran; [Shokati, Ameneh] Univ Tehran Med Sci, Neurosci Inst, Multiple Sclerosis Res Ctr, Tehran, Iran; [Tyagi, Poonam] Prince Sattam Bin Abdulaziz Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Riyadh, Saudi Arabia; [Ozturk, Alpaslan] Hlth Sci Univ, Ankara Diskapi Yildirim Beyazit Training & Res Hos, Dept Med Biochem, Ankara, Turkiye; [Nasimfar, Amir] Urmia Univ Med Sci, Fac Med, Dept Pediat, Orumiyeh, Iran; [Jalali, Ladan] Urmia Univ Med Sci, Sch Med, Dept Biochem, Orumiyeh, Iran en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 156253
gdc.description.volume 169 en_US
gdc.description.wosquality Q2
gdc.identifier.openalex W4379743204
gdc.identifier.pmid 37320963 en_US
gdc.identifier.wos WOS:001054021200001 en_US
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.impulse 22.0
gdc.oaire.influence 3.086183E-9
gdc.oaire.isgreen true
gdc.oaire.keywords Immunomodulatory effects
gdc.oaire.keywords Signal-Transduction
gdc.oaire.keywords C-Jun
gdc.oaire.keywords SARS-CoV-2
gdc.oaire.keywords Anti-Inflammatory Agents
gdc.oaire.keywords COVID-19
gdc.oaire.keywords Expression
gdc.oaire.keywords Severity
gdc.oaire.keywords Article
gdc.oaire.keywords Prolactin
gdc.oaire.keywords Activated Macrophages
gdc.oaire.keywords Release
gdc.oaire.keywords Immune System
gdc.oaire.keywords Growth-Hormone
gdc.oaire.keywords Mechanisms
gdc.oaire.keywords Necrosis-Factor-Alpha
gdc.oaire.keywords Humans
gdc.oaire.keywords RNA, Viral
gdc.oaire.keywords Cell
gdc.oaire.keywords Receptor
gdc.oaire.popularity 1.853236E-8
gdc.oaire.publicfunded false
gdc.openalex.collaboration International
gdc.openalex.fwci 8.40946942
gdc.openalex.normalizedpercentile 0.96
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 10
gdc.plumx.crossrefcites 1
gdc.plumx.facebookshareslikecount 20
gdc.plumx.mendeley 36
gdc.plumx.newscount 1
gdc.plumx.pubmedcites 9
gdc.plumx.scopuscites 19
gdc.scopus.citedcount 19
gdc.wos.citedcount 18
relation.isOrgUnitOfPublication b20623fc-1264-4244-9847-a4729ca7508c
relation.isOrgUnitOfPublication.latestForDiscovery b20623fc-1264-4244-9847-a4729ca7508c

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
5061.pdf
Size:
769.11 KB
Format:
Adobe Portable Document Format
Description:
Tam Metin / Full Text